financetom
Business
financetom
/
Business
/
EXPLAINER-What's in Nestle's sprawling food empire as new CEO wields axe?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EXPLAINER-What's in Nestle's sprawling food empire as new CEO wields axe?
Oct 16, 2025 10:17 AM

AMSTERDAM, Oct 16 (Reuters) - Nestle's new CEO

Philipp Navratil has started with a bang, announcing 16,000 job

cuts and a portfolio review that could see brands sold or

partnered off as the world's largest packaged food company looks

to focus on fast-growing areas.

Nestle's shares leapt 9.3% on Thursday, the biggest daily

rise since 2007, as investors welcomed the plans after a period

of management turmoil for the KitKat-to-Nescafe maker that saw

both the CEO and chairman depart in a month.

CEO Laurent Freixe was fired over an office relationship,

with Chairman Paul Bulcke stepping down shortly after to make

way for former Inditex chief Pablo Isla.

STRUGGLING UNITS: TO FIX, PARTNER, OR SELL?

Navratil is looking to sharpen the company's focus that

could put parts of an empire that spans vitamins, pet food,

coffee, confectionery, bottled water and more on the chopping

block.

"I will consistently review every part of our portfolio with

an open mind," Navratil said alongside third-quarter results,

adding this meant looking at whether brands are growing, the

returns are attractive and if Nestle is the market leader.

"If our assessment concludes that one or ... (another)

business does not meet the criteria I described, we will act,

whether that means fixing, partnering or selling."

NESTLE: A $245 BILLION MARKET CAP FOOD GIANT

Nestle, with a market value of about $245 billion, competes

with the likes of Unilever ( UL ), P&G, Kraft Heinz ( KHC )

, PepsiCo ( PEP ) and Danone.

Coffee brands Nescafe and Nespresso form a key part of

Nestle's top business unit, Powdered & Liquid Beverages, which

accounted for 18.4 billion Swiss francs ($23.1 billion), or

almost 28%, of sales for January-September.

PetCare, with brands such as Felix and Purina, had 13.6

billion francs of sales in that period and led on real internal

growth, a measure of sales volume that Nestle uses.

NESTLE REVIEWING CERTAIN UNITS, BRANDS FOR POTENTIAL SALE

Nutrition & Health Science includes Nestle's Vitamins,

Minerals and Supplements (VMS) division. In VMS, premium brands

grew strongly in the nine months, but a weaker performance

across some mainstream brands offset that.

Nestle is reviewing low-growth, low-margin VMS brands like

Nature's Bounty, Puritan's Pride and Osteo Bi-Flex that together

generate around 1 billion francs in annual sales.

It is also reassessing its Water business, which includes

Sanpellegrino and Vittel, accounting for under 4% of total

sales.

KitKat is Nestle's stand-out Confectionery performer and in

Prepared Dishes and Cooking Aids, it's Maggi seasoning.

($1 = 0.7957 Swiss francs)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
American Airlines forecasts bigger first-quarter loss
American Airlines forecasts bigger first-quarter loss
Mar 11, 2025
March 11 (Reuters) - American Airlines ( AAL ) on Tuesday forecast a bigger first-quarter loss, amid concerns that tariff pressures and government spending uncertainties could dampen travel demand. The airline now expects adjusted loss per share in the range of about 60 cents to 80 cents, compared with its previous forecast for a loss of about 20 cents to...
India's Bharti Airtel signs deal with SpaceX to bring Starlink internet in India
India's Bharti Airtel signs deal with SpaceX to bring Starlink internet in India
Mar 11, 2025
(Reuters) - India's Bharti Airtel said on Tuesday that it has signed a deal with SpaceX to bring Starlink internet in India. ...
Knight Therapeutics Buying Paladin Pharma for $120 Million
Knight Therapeutics Buying Paladin Pharma for $120 Million
Mar 11, 2025
07:11 AM EDT, 03/11/2025 (MT Newswires) -- Knight Therapeutics ( KHTRF ) on Tuesday said it is acquiring Paladin Pharma for $120 million in cash, including inventory valued at $20 million. Knight may pay up to an additional US$15 million if certain sales milestones are hit, according to a statement. In 2024, Paladin generated revenue of $70 million, the statement...
Pollard Banknote Swings to Net Loss in Q4 Despite Higher Revenue
Pollard Banknote Swings to Net Loss in Q4 Despite Higher Revenue
Mar 11, 2025
07:06 AM EDT, 03/11/2025 (MT Newswires) -- Pollard Banknote ( PBKOF ) late on Monday said it swung to a net loss in the fourth quarter despite an increase in revenue. The net loss was $1.8 million, or $0.06 per share, compared with income of $11.3 million, or $0.41 per share. Analysts surveyed by FactSet expected earnings of $0.34 per...
Copyright 2023-2026 - www.financetom.com All Rights Reserved